Test Price
1,200 AEDโ Home Collection Available
Glucose-6-Phosphate Dehydrogenase (G6PD) Gene Mutation Detection Test in UAE | 1200 AED | DHA Licensed
Executive Summary & Core Metrics
Diagnostic Accuracy: 99.9% sensitivity and specificity via ISO-15189 accredited molecular analysis.
Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Daily 8 AM โ 11 PM).
Clinical Support: Telephonic post-test genetic counseling and result interpretation.
Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Glucose-6-Phosphate Dehydrogenase (G6PD) Gene Mutation Detection test identifies pathogenic variants in the G6PD gene, providing a definitive molecular diagnosis for G6PD deficiencyโan X-linked recessive enzymopathy affecting red blood cell stability. This analysis is essential for at-risk individuals, pre-chemotherapy pharmacogenetic screening, and neonatal jaundice evaluation. Our methodology employs PCR-based Sanger sequencing targeting the full coding region and splice sites of the G6PD gene.
Our Test vs. Closest Alternative
| Parameter | Our G6PD Gene Mutation Test | G6PD Enzyme Activity Assay |
|---|---|---|
| Methodology | PCR + Sanger Sequencing (targeted full gene analysis) | Spectrophotometric enzyme activity |
| Turnaround Time | 10 Business Days (Monday sample before 11:00 AM) | 24โ48 Hours |
| Diagnostic Accuracy | 99.9% Sensitivity & Specificity for known mutations | ~95% Sensitivity; falsely normal post-hemolysis |
| Mutation Coverage | Detects all clinically relevant pathogenic variants | No mutation detection |
| Carrier Detection | Yes โ identifies heterozygous females | Not possible |
| Pharmacogenetic Guidance | Specific genotype-based drug risk stratification | General deficiency level only |
Physician Insight & Safety Protocols
"As a Consultant Medical Geneticist, I emphasize that definitive molecular diagnosis is critical for managing G6PD deficiency. The gene mutation test resolves ambiguous enzyme activity results, identifies female carriers, and guides safe pharmacotherapy decisions. Always discuss your results with a qualified physician."
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403)
Advisory & Clinical Guidance
โ Medication Warning
Do not discontinue prescribed medication without consulting your doctor. G6PD test results must be interpreted in conjunction with clinical history.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Blood transfusion within the last 3 months may interfere with genetic analysis. Inform our team before booking.
- Red Flag: If you experience sudden dark urine, jaundice, severe fatigue, or back pain, seek emergency medical care immediately. Do not wait for test results.
- Testing Minors: Per Federal Decree-Law No. 4 of 2016, a parent or legal guardian must provide written consent. The mandatory Genomics Clinical Information Requisition Form (Form 20) must be completed.
Patient FAQ & Clinical Guidance
1. What does the G6PD gene mutation test detect?
This test identifies pathogenic mutations in the G6PD gene responsible for glucose-6-phosphate dehydrogenase deficiency, an enzyme critical for red blood cell stability. The analysis provides a definitive genetic diagnosis, determines carrier status, and guides safe medication use (e.g., avoiding primaquine, dapsone, and certain chemotherapeutics).
2. How should I prepare for the G6PD gene test?
No fasting or special preparation is required. Simply ensure your healthcare provider completes the mandatory Genomics Clinical Information Requisition Form (Form 20). Our home collection team will draw 4 mL of blood in a lavender-top EDTA tube under cold-chain conditions. Avoid blood transfusions for 3 months prior if possible.
3. What do my G6PD gene results mean for my health?
A positive result indicates you carry a G6PD gene mutation, classifying you as G6PD-deficient, which may predispose you to drug-induced hemolytic anemia. Negative results rule out known pathogenic mutations, but your doctor may consider enzyme activity testing if clinical suspicion remains high. Heterozygous females (carriers) typically have moderate enzyme activity and require personalized advice.
UAE Regulatory & Data Privacy Adherence
This service complies with all UAE federal health regulations. Data security adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability. All genetic data is processed with strict confidentiality and ISO-compliant quality management.
Clinical & Logistical Metadata
| Test Name | Glucose-6-Phosphate Dehydrogenase (G6PD) Gene Mutation Detection |
| Price (AED) | 1,200 AED |
| Turnaround Time | 10 Business Days (Monday sample before 11:00 AM) |
| Sample Type / Matrix | Peripheral Whole Blood (4 mL in Lavender-Top EDTA Tube) |
| Methodology Used | PCR + Sanger Sequencing (Full G6PD Gene Analysis) |
| ICD-10-CM Code | D55.0 (Anemia due to glucose-6-phosphate dehydrogenase deficiency) |
| LOINC Code | 21660-8 (G6PD gene mutation analysis) |
| DHA Facility License & Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
For booking & insurance verification, WhatsApp +971 54 548 8731. VIP Home Collection available daily from 8 AM to 11 PM.
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians